The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center
Open accessAbstract
Military medical facilities treating patients injured in Iraq and Afghanistan have identified a large number of multidrug-resistant (MDR) Acinetobacter baumannii isolates. In order to anticipate the impact of these pathogens on patient care, we analyzed the antibiotic resistance genes responsible for the MDR phenotype in Acinetobacter sp. isolates collected from patients at the Walter Reed Army Medical Center (WRAMC). Susceptibility testing, PCR amplification of the genetic determinants of resistance, and clonality were determined. Seventy-five unique patient isolates were included in this study: 53% were from bloodstream infections, 89% were resistant to at least three classes of antibiotics, and 15% were resistant to all nine antibiotics tested. Thirty-seven percent of the isolates were recovered from patients nosocomially infected or colonized at the WRAMC. Sixteen unique resistance genes or gene families and four mobile genetic elements were detected. In addition, this is the first report of bla OXA-58 -like and bla PER -like genes in the U.S. MDR A. baumannii isolates with at least eight identified resistance determinants were recovered from 49 of the 75 patients. Molecular typing revealed multiple clones, with eight major clonal types being nosocomially acquired and with more than 60% of the isolates being related to three pan-European types. This report gives a “snapshot” of the complex genetic background responsible for antimicrobial resistance in Acinetobacter spp. from the WRAMC. Identifying genes associated with the MDR phenotype and defining patterns of transmission serve as a starting point for devising strategies to limit the clinical impact of these serious infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Baker, S. P., O’Neill, B., Haddon, W. F., & Long, W. B. (1974) · PubMed · Cited by 7,946
BAKER, S. P., OʼNEILL, B., HADDON, W., & LONG, W. B. (1974) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-197403000-00001 · Cited by 7,292
Nosocomial infections in medical intensive care units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., & Gaynes, R. P. (1999) · Critical Care Medicine · doi:10.1097/00003246-199905000-00020 · Cited by 1,565
Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii
Fournier, P.-E., Vallenet, D., Barbe, V., Audic, S., Ogata, H., Poirel, L., Richet, H., Robert, C., Mangenot, S., Abergel, C., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020007 · Cited by 812
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M., & Pitt, T. L. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00195.x · Cited by 751
Magnet, S., Courvalin, P., & Lambert, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3375-3380.2001 · Cited by 575
Marchand, I., Damier-Piolle, L., Courvalin, P., & Lambert, T. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3298-3304.2004 · Cited by 407
Paterson, D. L., Hujer, K. M., Hujer, A. M., Yeiser, B., Bonomo, M. D., Rice, L. B., Bonomo, R. A., & the International Klebsiella Study Group (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3554-3560.2003 · Cited by 394
Self-citationCharacterization of the Naturally Occurring Oxacillinase of Acinetobacter baumannii
Héritier, C., Poirel, L., Fournier, P.-E., Claverie, J.-M., Raoult, D., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4174-4179.2005 · Cited by 286
Multidrug-Resistant Acinetobacter baumannii
Abbo, A., Navon-Venezia, S., Hammer-Muntz, O., Krichali, T., Siegman-Igra, Y., & Carmeli, Y. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1101.040001 · Cited by 285
Héritier, C., Poirel, L., Lambert, T., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3198-3202.2005 · Cited by 272
Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii
Héritier, C., Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01320.x · Cited by 266
Emergence of Plasmid-Mediated Quinolone Resistance in Escherichia coli in Europe
Mammeri, H., Van De Loo, M., Poirel, L., Martinez-Martinez, L., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.71-76.2005 · Cited by 261
Riccio, M. L., Franceschini, N., Boschi, L., Caravelli, B., Cornaglia, G., Fontana, R., Amicosante, G., & Rossolini, G. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1229-1235.2000 · Cited by 249
Donald, H. M., Scaife, W., Amyes, S. G. B., & Young, H.-K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.196-199.2000 · Cited by 235
Nemec, A. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45716-0 · Cited by 226
Multidrug-Resistant Acinetobacter Infections: An Emerging Challenge to Clinicians
Jain, R., & Danziger, L. H. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d592 · Cited by 219
Characterisation of two new gene cassettes, aadA5 and dfrA17
White, P. (2000) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(99)00600-x · Cited by 203
Rapid identification and strain-typing of respiratory pathogens for epidemic surveillance
Ecker, D. J., Sampath, R., Blyn, L. B., Eshoo, M. W., Ivy, C., Ecker, J. A., Libby, B., Samant, V., Sannes-Lowery, K. A., Melton, R. E., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409920102 · Cited by 172
Self-citationEcker, J. A., Massire, C., Hall, T. A., Ranken, R., Pennella, T.-T. D., Agasino Ivy, C., Blyn, L. B., Hofstadler, S. A., Endy, T. P., Scott, P. T., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00619-06 · Cited by 163
Self-citationCalfee, D. P., Durbin, L. J., Germanson, T. P., TONEY, D. M., Smith, E. B., & Farr, B. M. (2003) · Infection Control and Hospital Epidemiology · doi:10.1086/502225 · Cited by 149
Turton, J. F., Kaufmann, M. E., Glover, J., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3074-3082.2005 · Cited by 146
Rice, L. B., Carias, L. L., Hujer, A. M., Bonafede, M., Hutton, R. A., Hoyen, C. K., & Bonomo, R. A. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.362-367.2000 · Cited by 134
Self-citationCoelho, J., Woodford, N., Afzal-Shah, M., & Livermore, D. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.756-758.2006 · Cited by 104
Sun, T., Nukaga, M., Mayama, K., Braswell, E. H., & Knox, J. R. (2003) · Protein Science · doi:10.1110/ps.0224303 · Cited by 102
Transferable production of PER-1 β-lactamase in Pseudomonas aeruginosa
Danel, F., Hall, L. M. C., Gür, D., Akalın, H., & Livermore, D. M. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.2.281 · Cited by 91
Vancomycin-resistant enterococci: consequences for therapy and infection control
Mascini, E. M., & Bonten, M. J. M. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01164.x · Cited by 83
Novel Resistance-Nodulation-Cell Division Efflux System AdeDE in Acinetobacter Genomic DNA Group 3
Chau, S.-L., Chu, Y.-W., & Houang, E. T. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.4054-4055.2004 · Cited by 73
Nosocomial Infections Caused by Acinetobacter baumannii A Major Threat Worldwide
Richet, H., & Fournier, P. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/505900 · Cited by 73
Hujer, A. M., Hujer, K. M., & Bonomo, R. A. (2001) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(01)00164-9 · Cited by 61
Self-citation
Cited by
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Self-citationCarbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Self-citationGlobal Challenge of Multidrug-Resistant Acinetobacter baumannii
Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., & Bonomo, R. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01464-06 · Cited by 1,139
Self-citationMaragakis, L. L., & Perl, T. M. (2008) · Clinical Infectious Diseases · doi:10.1086/529198 · Cited by 969
Metadata
- Authors
- Hujer, K. M., Hujer, A. M., Hulten, E. A., Bajaksouzian, S., Adams, J. M., Donskey, C. J., Ecker, D. J., Massire, C., Eshoo, M. W., Sampath, R., Thomson, J. M., Rather, P. N., Craft, D. W., Fishbain, J. T., Ewell, A. J., Jacobs, M. R., Paterson, D. L., & Bonomo, R. A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2006-12
- Volume
- 50
- Issue
- 12
- Pages
- 4114-4123
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2074663598
- Cited by
- 480
- References
- 31
- FWCI
- 11.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.